TGF-β signaling promotes cervical cancer metastasis via CDR1as

Abstract Background Due to the lack of effective treatment, metastasis is the main cause of cancer related deaths. TGF-β pathway has been reported related to cervical cancer metastasis. However, mechanism is still unclear. Methods After agonist of TGF-β treatment, RNA sequencing revealed the express...

Full description

Bibliographic Details
Main Authors: Guanglei Zhong, Qian Zhao, Zhiliao Chen, Tingting Yao
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Molecular Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12943-023-01743-9
_version_ 1797853975635034112
author Guanglei Zhong
Qian Zhao
Zhiliao Chen
Tingting Yao
author_facet Guanglei Zhong
Qian Zhao
Zhiliao Chen
Tingting Yao
author_sort Guanglei Zhong
collection DOAJ
description Abstract Background Due to the lack of effective treatment, metastasis is the main cause of cancer related deaths. TGF-β pathway has been reported related to cervical cancer metastasis. However, mechanism is still unclear. Methods After agonist of TGF-β treatment, RNA sequencing revealed the expression profiles of circRNA in cervical cancer. In situ hybridization was used to analysis relationship between CDR1as and prognosis. Real-time PCR, Western blot, RNA interference, Transwell assay, Wound healing assay, RNA pulldown assay and RIP assays were performed in vitro. And in vivo cervical cancer model (including foot pad model and subcutaneous tumor formation) was also performed. Results CDR1as was found upregulated obviously following TGF-β activation. In situ hybridization showed CDR1as was positively correlated with lymph node metastasis and shortened survival length. Simultaneously, overexpression of CDR1as promoted cervical cancer metastasis in vitro and in vivo. It was also found that CDR1as could facilitate the orchestration of IGF2BP1 on the mRNA of SLUG and stabilize it from degradation. Silencing IGF2BP1 hampers CDR1as related metastasis in cervical cancer. Additionally, effective CDR1as has been proven to activate TGF-β signaling factors known to promote EMT, including P-Smad2 and P-Smad3. Conclusions Our study proved TGF-β signaling may promote cervical cancer metastasis via CDR1as.
first_indexed 2024-04-09T19:59:25Z
format Article
id doaj.art-396d22506a86425e9f17396fd843172a
institution Directory Open Access Journal
issn 1476-4598
language English
last_indexed 2024-04-09T19:59:25Z
publishDate 2023-03-01
publisher BMC
record_format Article
series Molecular Cancer
spelling doaj.art-396d22506a86425e9f17396fd843172a2023-04-03T05:18:47ZengBMCMolecular Cancer1476-45982023-03-0122111210.1186/s12943-023-01743-9TGF-β signaling promotes cervical cancer metastasis via CDR1asGuanglei Zhong0Qian Zhao1Zhiliao Chen2Tingting Yao3Department of Gynecological Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityDepartment of Gynecological Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityDepartment of Gynecological Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityDepartment of Gynecological Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityAbstract Background Due to the lack of effective treatment, metastasis is the main cause of cancer related deaths. TGF-β pathway has been reported related to cervical cancer metastasis. However, mechanism is still unclear. Methods After agonist of TGF-β treatment, RNA sequencing revealed the expression profiles of circRNA in cervical cancer. In situ hybridization was used to analysis relationship between CDR1as and prognosis. Real-time PCR, Western blot, RNA interference, Transwell assay, Wound healing assay, RNA pulldown assay and RIP assays were performed in vitro. And in vivo cervical cancer model (including foot pad model and subcutaneous tumor formation) was also performed. Results CDR1as was found upregulated obviously following TGF-β activation. In situ hybridization showed CDR1as was positively correlated with lymph node metastasis and shortened survival length. Simultaneously, overexpression of CDR1as promoted cervical cancer metastasis in vitro and in vivo. It was also found that CDR1as could facilitate the orchestration of IGF2BP1 on the mRNA of SLUG and stabilize it from degradation. Silencing IGF2BP1 hampers CDR1as related metastasis in cervical cancer. Additionally, effective CDR1as has been proven to activate TGF-β signaling factors known to promote EMT, including P-Smad2 and P-Smad3. Conclusions Our study proved TGF-β signaling may promote cervical cancer metastasis via CDR1as.https://doi.org/10.1186/s12943-023-01743-9Cervical cancerMetastasisTGF-βCDR1asSlugIGF2BP1
spellingShingle Guanglei Zhong
Qian Zhao
Zhiliao Chen
Tingting Yao
TGF-β signaling promotes cervical cancer metastasis via CDR1as
Molecular Cancer
Cervical cancer
Metastasis
TGF-β
CDR1as
Slug
IGF2BP1
title TGF-β signaling promotes cervical cancer metastasis via CDR1as
title_full TGF-β signaling promotes cervical cancer metastasis via CDR1as
title_fullStr TGF-β signaling promotes cervical cancer metastasis via CDR1as
title_full_unstemmed TGF-β signaling promotes cervical cancer metastasis via CDR1as
title_short TGF-β signaling promotes cervical cancer metastasis via CDR1as
title_sort tgf β signaling promotes cervical cancer metastasis via cdr1as
topic Cervical cancer
Metastasis
TGF-β
CDR1as
Slug
IGF2BP1
url https://doi.org/10.1186/s12943-023-01743-9
work_keys_str_mv AT guangleizhong tgfbsignalingpromotescervicalcancermetastasisviacdr1as
AT qianzhao tgfbsignalingpromotescervicalcancermetastasisviacdr1as
AT zhiliaochen tgfbsignalingpromotescervicalcancermetastasisviacdr1as
AT tingtingyao tgfbsignalingpromotescervicalcancermetastasisviacdr1as